Here’s what you should know:
1. BidaskClub assigned Surgery Partners a sell rating in its latest research note.
2. Stifel Nicolaus assigned the company a hold rating, but dropped its price objective from $19 a share to $18 a share.
3. On average analysts project a price target of $21.40 for Surgery Partners.
4. Surgery Partners closed Jan. 24 at $21.38.
More articles on transactions/valuations:
Concord Orthopaedics’ ASC plans up in the air due to rezoning concerns: 4 takeaways
Compass Surgical Partners opens multispecialty ASC & more — 5 ASC company key notes
Compass Surgical Partners opens freestanding Florida ASC: 4 key points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
